Kawasaki disease following immunization reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018
Kawasaki disease (KD) is an acute systemic vasculitis primarily affecting children younger than 5 y of age that has been reported as an adverse event following immunization (AEFI). The Canadian Immunization Monitoring Program ACTive (IMPACT) conducts active surveillance for KD following immunization...
Main Authors: | Khaled Alsager, Nirma Khatri Vadlamudi, Taj Jadavji, Julie A. Bettinger, Cora Constantinescu, Wendry Vaudry, Ben Tan, Laura Sauvé, Manish Sadarangani, Scott A. Halperin, Karina A. Top, for the IMPACT Investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2022.2088215 |
Similar Items
-
Atypical Kawasaki Disease after COVID-19 Vaccination: A New Form of Adverse Event Following Immunization
by: Ana Lilia Peralta-Amaro, et al.
Published: (2022-01-01) -
Two case reports of skin vasculitis following the COVID-19 immunization
by: Chomičienė Anželika, et al.
Published: (2022-12-01) -
Emerging evidence of microbial infection in causing systematic immune vasculitis in Kawasaki disease
by: Wang Wang, et al.
Published: (2023-12-01) -
Post COVID vaccination (COVAXIN™ -BB152 V) pauci-immune crescentic glomerulonephritis
by: Shyam B Bansal, et al.
Published: (2022-01-01) -
Is ‘conflict of interest’ a Misnomer? Managing interests in immunization research and evaluation
by: Elisabeth McClymont, et al.
Published: (2022-01-01)